Gracell Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 314

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.2B

Gracell General Information

Description

Operator of a clinical-stage biopharmaceutical company intended to develop cancer immune therapy designed to treat cancer. The company offers CAR-T therapies for solid tumors and autoimmune diseases, enabling patients to avail of cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer.

Contact Information

Website
www.gracellbio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Floor 41, Number 188, Hongbaoshi Road
  • Changning District
  • Shanghai
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
AstraZeneca
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Floor 41, Number 188, Hongbaoshi Road
  • Changning District
  • Shanghai
  • China

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gracell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 22-Feb-2024 $1.2B Completed Generating Revenue
10. PIPE 10-Aug-2023 Completed Generating Revenue
9. IPO 08-Jan-2021 Completed Clinical Trials - Phase 1
8. Later Stage VC (Series C) 28-Oct-2020 Completed Clinical Trials - Phase 1
7. Debt - General 10-Sep-2020 Completed Pre-Clinical Trials
6. Debt - General 16-Jul-2020 Completed Pre-Clinical Trials
5. Debt - General 11-May-2020 Completed Pre-Clinical Trials
4. Debt - General 15-Jan-2020 Completed Pre-Clinical Trials
3. Early Stage VC (Series B) 25-Feb-2019 $85M $95M Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 15-Nov-2017 $10M $10M Completed Startup
To view Gracell’s complete valuation and funding history, request access »

Gracell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biopharmaceutical company intended to develop cancer immune therapy designed to treat cance
Drug Discovery
Shanghai, China
314 As of 2022

Santa Monica, CA
 

Beijing, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gracell Competitors (39)

One of Gracell’s 39 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA
Mabworks Biotech Venture Capital-Backed Beijing, China
Meditope Biosciences Venture Capital-Backed Pasadena, CA
IASO Bio Venture Capital-Backed Nanjing, China
JW Therapeutics Formerly VC-backed Shanghai, China
You’re viewing 5 of 39 competitors. Get the full list »

Gracell Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 22

    Pending

  • Expiring in next 12 mo

Gracell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250064855-A1 Use of dual-target car-t cells in treating b-cell autoimmune diseases Pending 10-Aug-2023
EP-4457339-A1 Systems and methods for cell modification Pending 27-Dec-2021
JP-2025500531-A Systems and methods for cell modification Pending 27-Dec-2021
EP-4410966-A1 Chimeric antigen receptor immune cell, and preparation method therefor and application thereof Pending 29-Sep-2021
US-20240408199-A1 Chimeric antigen receptor immune cell, and preparation method therefor and application thereof Pending 29-Sep-2021 A61K40/4202
To view Gracell’s complete patent history, request access »

Gracell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gracell Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
6 Dimensions Capital Venture Capital Minority
Adage Capital Management Hedge Fund Minority
Exome Asset Management Asset Manager Minority
Janus Henderson Investors Asset Manager Minority
King Star Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial

Gracell FAQs

  • When was Gracell founded?

    Gracell was founded in 2017.

  • Where is Gracell headquartered?

    Gracell is headquartered in Shanghai, China.

  • What is the size of Gracell?

    Gracell has 314 total employees.

  • What industry is Gracell in?

    Gracell’s primary industry is Drug Discovery.

  • Is Gracell a private or public company?

    Gracell is a Private company.

  • What is the current valuation of Gracell?

    The current valuation of Gracell is .

  • What is Gracell’s current revenue?

    The current revenue for Gracell is .

  • How much funding has Gracell raised over time?

    Gracell has raised $526M.

  • Who are Gracell’s investors?

    6 Dimensions Capital, Adage Capital Management, Exome Asset Management, Janus Henderson Investors, and King Star Capital are 5 of 16 investors who have invested in Gracell.

  • Who are Gracell’s competitors?

    Kite Pharma, Mabworks Biotech, Meditope Biosciences, IASO Bio, and JW Therapeutics are some of the 39 competitors of Gracell.

  • When was Gracell acquired?

    Gracell was acquired on 22-Feb-2024.

  • Who acquired Gracell?

    Gracell was acquired by AstraZeneca.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »